Treating Lower Urinary Tract Infection in Men Without Prostatitis
This protocol addresses lower urinary tract infection in male patients where prostatitis has been clinically excluded. The absence of prostate involvement directly shapes both the duration and the selection of therapy.
Clinical Scenario
The patient is male and presents with lower urinary tract symptoms. There is no clinical evidence of prostatitis. For uncomplicated cystitis in men, a treatment duration of approximately 7 days is appropriate when prostate involvement has been excluded — a distinction from female-pattern uncomplicated cystitis and from male UTI with suspected prostate involvement.
Treatment Goals
- Improvement of dysuria
- Resolution of urinary frequency and urgency
- Relief of suprapubic pain
- Symptom improvement expected within 48–72 hours of starting treatment
Treatment Approach
Management centres on a short oral antibiotic course. The preferred agent is chosen based on individual patient factors; alternatives exist for patients in whom the primary agent cannot be used. The complete regimen — including agent selection, sequencing, and criteria for switching — is detailed in the full structured protocol.
Full drug selection, dosing guidance, and decision logic are in the protocol below.
References
DOI: 10.1053/j.ajkd.2023.08.009
- For uncomplicated cystitis in men, consider duration of ~7 days provided there is no evidence of prostatitis.
- One of the main first-line agents for the treatment of acute uncomplicated cystitis is oral nitrofurantoin for 5 days.
- Fosfomycin is an acceptable alternative if nitrofurantoin cannot be used.
- Trimethoprim-sulfamethoxazole can also be used empirically as a first-line agent except in cases where local resistance rates to Enterobacteriales (like E coli) exceed 20% or in patients who have used trimethoprim-sulfamethoxazole for an infection in the past 3 months.
View source ↗